The global Treatment for Gastroparesis market was valued at US$ 5659 million in 2023 and is anticipated to reach US$ 7645.5 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.

Treatment for Gastroparesis Market

Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Treatment for Gastroparesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Treatment for Gastroparesis.

Report Scope

The Treatment for Gastroparesis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Treatment for Gastroparesis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Treatment for Gastroparesis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Treatment for Gastroparesis Market Report

Report Metric	Details
Report Name	Treatment for Gastroparesis Market
Accounted market size in 2023	US$ 5659 million
Forecasted market size in 2030	US$ 7645.5 million
CAGR	4.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Drugs Surgical Treatment Products
Segment by Application	Hospital Pharmacies Private Clinics Drug Stores Retail Pharmacies E-Commerce
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Janssen Global Services, Evoke Pharma, Cardinal Health, Salix Pharmaceuticals, Alfa Wassermann, Abbott Laboratories, Medtronic, C.R.Bard, Rhythm Pharmaceuticals, Boston Scientific, Kimberly-Clark
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Treatment for Gastroparesis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Treatment for Gastroparesis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Treatment for Gastroparesis Market growing?

Ans: The Treatment for Gastroparesis Market witnessing a CAGR of 4.3% during the forecast period 2024-2030.

What is the Treatment for Gastroparesis Market size in 2030?

Ans: The Treatment for Gastroparesis Market size in 2030 will be US$ 7645.5 million.

Who are the main players in the Treatment for Gastroparesis Market report?

Ans: The main players in the Treatment for Gastroparesis Market are Janssen Global Services, Evoke Pharma, Cardinal Health, Salix Pharmaceuticals, Alfa Wassermann, Abbott Laboratories, Medtronic, C.R.Bard, Rhythm Pharmaceuticals, Boston Scientific, Kimberly-Clark

What are the Application segmentation covered in the Treatment for Gastroparesis Market report?

Ans: The Applications covered in the Treatment for Gastroparesis Market report are Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce

What are the Type segmentation covered in the Treatment for Gastroparesis Market report?

Ans: The Types covered in the Treatment for Gastroparesis Market report are Drugs, Surgical Treatment Products

1 Treatment for Gastroparesis Market Overview

1.1 Product Overview and Scope of Treatment for Gastroparesis

1.2 Treatment for Gastroparesis Segment by Type

1.2.1 Global Treatment for Gastroparesis Market Value Comparison by Type (2024-2030)

1.2.2 Drugs

1.2.3 Surgical Treatment Products

1.3 Treatment for Gastroparesis Segment by Application

1.3.1 Global Treatment for Gastroparesis Market Value by Application: (2024-2030)

1.3.2 Hospital Pharmacies

1.3.3 Private Clinics

1.3.4 Drug Stores

1.3.5 Retail Pharmacies

1.3.6 E-Commerce

1.4 Global Treatment for Gastroparesis Market Size Estimates and Forecasts

1.4.1 Global Treatment for Gastroparesis Revenue 2019-2030

1.4.2 Global Treatment for Gastroparesis Sales 2019-2030

1.4.3 Global Treatment for Gastroparesis Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Treatment for Gastroparesis Market Competition by Manufacturers

2.1 Global Treatment for Gastroparesis Sales Market Share by Manufacturers (2019-2024)

2.2 Global Treatment for Gastroparesis Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Treatment for Gastroparesis Average Price by Manufacturers (2019-2024)

2.4 Global Treatment for Gastroparesis Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Treatment for Gastroparesis, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Treatment for Gastroparesis, Product Type & Application

2.7 Treatment for Gastroparesis Market Competitive Situation and Trends

2.7.1 Treatment for Gastroparesis Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Treatment for Gastroparesis Players Market Share by Revenue

2.7.3 Global Treatment for Gastroparesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Treatment for Gastroparesis Retrospective Market Scenario by Region

3.1 Global Treatment for Gastroparesis Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Treatment for Gastroparesis Global Treatment for Gastroparesis Sales by Region: 2019-2030

3.2.1 Global Treatment for Gastroparesis Sales by Region: 2019-2024

3.2.2 Global Treatment for Gastroparesis Sales by Region: 2025-2030

3.3 Global Treatment for Gastroparesis Global Treatment for Gastroparesis Revenue by Region: 2019-2030

3.3.1 Global Treatment for Gastroparesis Revenue by Region: 2019-2024

3.3.2 Global Treatment for Gastroparesis Revenue by Region: 2025-2030

3.4 North America Treatment for Gastroparesis Market Facts & Figures by Country

3.4.1 North America Treatment for Gastroparesis Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Treatment for Gastroparesis Sales by Country (2019-2030)

3.4.3 North America Treatment for Gastroparesis Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Treatment for Gastroparesis Market Facts & Figures by Country

3.5.1 Europe Treatment for Gastroparesis Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Treatment for Gastroparesis Sales by Country (2019-2030)

3.5.3 Europe Treatment for Gastroparesis Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Treatment for Gastroparesis Market Facts & Figures by Country

3.6.1 Asia Pacific Treatment for Gastroparesis Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Treatment for Gastroparesis Sales by Country (2019-2030)

3.6.3 Asia Pacific Treatment for Gastroparesis Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Treatment for Gastroparesis Market Facts & Figures by Country

3.7.1 Latin America Treatment for Gastroparesis Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Treatment for Gastroparesis Sales by Country (2019-2030)

3.7.3 Latin America Treatment for Gastroparesis Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Treatment for Gastroparesis Market Facts & Figures by Country

3.8.1 Middle East and Africa Treatment for Gastroparesis Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Treatment for Gastroparesis Sales by Country (2019-2030)

3.8.3 Middle East and Africa Treatment for Gastroparesis Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Treatment for Gastroparesis Sales by Type (2019-2030)

4.1.1 Global Treatment for Gastroparesis Sales by Type (2019-2024)

4.1.2 Global Treatment for Gastroparesis Sales by Type (2025-2030)

4.1.3 Global Treatment for Gastroparesis Sales Market Share by Type (2019-2030)

4.2 Global Treatment for Gastroparesis Revenue by Type (2019-2030)

4.2.1 Global Treatment for Gastroparesis Revenue by Type (2019-2024)

4.2.2 Global Treatment for Gastroparesis Revenue by Type (2025-2030)

4.2.3 Global Treatment for Gastroparesis Revenue Market Share by Type (2019-2030)

4.3 Global Treatment for Gastroparesis Price by Type (2019-2030)

5 Segment by Application

5.1 Global Treatment for Gastroparesis Sales by Application (2019-2030)

5.1.1 Global Treatment for Gastroparesis Sales by Application (2019-2024)

5.1.2 Global Treatment for Gastroparesis Sales by Application (2025-2030)

5.1.3 Global Treatment for Gastroparesis Sales Market Share by Application (2019-2030)

5.2 Global Treatment for Gastroparesis Revenue by Application (2019-2030)

5.2.1 Global Treatment for Gastroparesis Revenue by Application (2019-2024)

5.2.2 Global Treatment for Gastroparesis Revenue by Application (2025-2030)

5.2.3 Global Treatment for Gastroparesis Revenue Market Share by Application (2019-2030)

5.3 Global Treatment for Gastroparesis Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Janssen Global Services

6.1.1 Janssen Global Services Corporation Information

6.1.2 Janssen Global Services Description and Business Overview

6.1.3 Janssen Global Services Treatment for Gastroparesis Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Janssen Global Services Treatment for Gastroparesis Product Portfolio

6.1.5 Janssen Global Services Recent Developments/Updates

6.2 Evoke Pharma

6.2.1 Evoke Pharma Corporation Information

6.2.2 Evoke Pharma Description and Business Overview

6.2.3 Evoke Pharma Treatment for Gastroparesis Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Evoke Pharma Treatment for Gastroparesis Product Portfolio

6.2.5 Evoke Pharma Recent Developments/Updates

6.3 Cardinal Health

6.3.1 Cardinal Health Corporation Information

6.3.2 Cardinal Health Description and Business Overview

6.3.3 Cardinal Health Treatment for Gastroparesis Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Cardinal Health Treatment for Gastroparesis Product Portfolio

6.3.5 Cardinal Health Recent Developments/Updates

6.4 Salix Pharmaceuticals

6.4.1 Salix Pharmaceuticals Corporation Information

6.4.2 Salix Pharmaceuticals Description and Business Overview

6.4.3 Salix Pharmaceuticals Treatment for Gastroparesis Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Salix Pharmaceuticals Treatment for Gastroparesis Product Portfolio

6.4.5 Salix Pharmaceuticals Recent Developments/Updates

6.5 Alfa Wassermann

6.5.1 Alfa Wassermann Corporation Information

6.5.2 Alfa Wassermann Description and Business Overview

6.5.3 Alfa Wassermann Treatment for Gastroparesis Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Alfa Wassermann Treatment for Gastroparesis Product Portfolio

6.5.5 Alfa Wassermann Recent Developments/Updates

6.6 Abbott Laboratories

6.6.1 Abbott Laboratories Corporation Information

6.6.2 Abbott Laboratories Description and Business Overview

6.6.3 Abbott Laboratories Treatment for Gastroparesis Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Abbott Laboratories Treatment for Gastroparesis Product Portfolio

6.6.5 Abbott Laboratories Recent Developments/Updates

6.7 Medtronic

6.6.1 Medtronic Corporation Information

6.6.2 Medtronic Description and Business Overview

6.6.3 Medtronic Treatment for Gastroparesis Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Medtronic Treatment for Gastroparesis Product Portfolio

6.7.5 Medtronic Recent Developments/Updates

6.8 C.R.Bard

6.8.1 C.R.Bard Corporation Information

6.8.2 C.R.Bard Description and Business Overview

6.8.3 C.R.Bard Treatment for Gastroparesis Sales, Revenue and Gross Margin (2019-2024)

6.8.4 C.R.Bard Treatment for Gastroparesis Product Portfolio

6.8.5 C.R.Bard Recent Developments/Updates

6.9 Rhythm Pharmaceuticals

6.9.1 Rhythm Pharmaceuticals Corporation Information

6.9.2 Rhythm Pharmaceuticals Description and Business Overview

6.9.3 Rhythm Pharmaceuticals Treatment for Gastroparesis Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Rhythm Pharmaceuticals Treatment for Gastroparesis Product Portfolio

6.9.5 Rhythm Pharmaceuticals Recent Developments/Updates

6.10 Boston Scientific

6.10.1 Boston Scientific Corporation Information

6.10.2 Boston Scientific Description and Business Overview

6.10.3 Boston Scientific Treatment for Gastroparesis Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Boston Scientific Treatment for Gastroparesis Product Portfolio

6.10.5 Boston Scientific Recent Developments/Updates

6.11 Kimberly-Clark

6.11.1 Kimberly-Clark Corporation Information

6.11.2 Kimberly-Clark Treatment for Gastroparesis Description and Business Overview

6.11.3 Kimberly-Clark Treatment for Gastroparesis Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Kimberly-Clark Treatment for Gastroparesis Product Portfolio

6.11.5 Kimberly-Clark Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Treatment for Gastroparesis Industry Chain Analysis

7.2 Treatment for Gastroparesis Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Treatment for Gastroparesis Production Mode & Process

7.4 Treatment for Gastroparesis Sales and Marketing

7.4.1 Treatment for Gastroparesis Sales Channels

7.4.2 Treatment for Gastroparesis Distributors

7.5 Treatment for Gastroparesis Customers

8 Treatment for Gastroparesis Market Dynamics

8.1 Treatment for Gastroparesis Industry Trends

8.2 Treatment for Gastroparesis Market Drivers

8.3 Treatment for Gastroparesis Market Challenges

8.4 Treatment for Gastroparesis Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Janssen Global Services

Evoke Pharma

Cardinal Health

Salix Pharmaceuticals

Rhythm Pharmaceuticals

Boston Scientific

Kimberly clark

List of Tables

Table 1. Global Treatment for Gastroparesis Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Treatment for Gastroparesis Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Treatment for Gastroparesis Market Competitive Situation by Manufacturers in 2023

Table 4. Global Treatment for Gastroparesis Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Treatment for Gastroparesis Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Treatment for Gastroparesis Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Treatment for Gastroparesis Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Treatment for Gastroparesis Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Treatment for Gastroparesis, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Treatment for Gastroparesis, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Treatment for Gastroparesis, Product Type & Application

Table 12. Global Key Manufacturers of Treatment for Gastroparesis, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Treatment for Gastroparesis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatment for Gastroparesis as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Treatment for Gastroparesis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Treatment for Gastroparesis Sales by Region (2019-2024) & (K Units)

Table 18. Global Treatment for Gastroparesis Sales Market Share by Region (2019-2024)

Table 19. Global Treatment for Gastroparesis Sales by Region (2025-2030) & (K Units)

Table 20. Global Treatment for Gastroparesis Sales Market Share by Region (2025-2030)

Table 21. Global Treatment for Gastroparesis Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Treatment for Gastroparesis Revenue Market Share by Region (2019-2024)

Table 23. Global Treatment for Gastroparesis Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Treatment for Gastroparesis Revenue Market Share by Region (2025-2030)

Table 25. North America Treatment for Gastroparesis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Treatment for Gastroparesis Sales by Country (2019-2024) & (K Units)

Table 27. North America Treatment for Gastroparesis Sales by Country (2025-2030) & (K Units)

Table 28. North America Treatment for Gastroparesis Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Treatment for Gastroparesis Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Treatment for Gastroparesis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Treatment for Gastroparesis Sales by Country (2019-2024) & (K Units)

Table 32. Europe Treatment for Gastroparesis Sales by Country (2025-2030) & (K Units)

Table 33. Europe Treatment for Gastroparesis Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Treatment for Gastroparesis Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Treatment for Gastroparesis Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Treatment for Gastroparesis Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Treatment for Gastroparesis Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Treatment for Gastroparesis Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Treatment for Gastroparesis Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Treatment for Gastroparesis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Treatment for Gastroparesis Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Treatment for Gastroparesis Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Treatment for Gastroparesis Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Treatment for Gastroparesis Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Treatment for Gastroparesis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Treatment for Gastroparesis Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Treatment for Gastroparesis Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Treatment for Gastroparesis Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Treatment for Gastroparesis Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Treatment for Gastroparesis Sales (K Units) by Type (2019-2024)

Table 51. Global Treatment for Gastroparesis Sales (K Units) by Type (2025-2030)

Table 52. Global Treatment for Gastroparesis Sales Market Share by Type (2019-2024)

Table 53. Global Treatment for Gastroparesis Sales Market Share by Type (2025-2030)

Table 54. Global Treatment for Gastroparesis Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Treatment for Gastroparesis Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Treatment for Gastroparesis Revenue Market Share by Type (2019-2024)

Table 57. Global Treatment for Gastroparesis Revenue Market Share by Type (2025-2030)

Table 58. Global Treatment for Gastroparesis Price (US$/Unit) by Type (2019-2024)

Table 59. Global Treatment for Gastroparesis Price (US$/Unit) by Type (2025-2030)

Table 60. Global Treatment for Gastroparesis Sales (K Units) by Application (2019-2024)

Table 61. Global Treatment for Gastroparesis Sales (K Units) by Application (2025-2030)

Table 62. Global Treatment for Gastroparesis Sales Market Share by Application (2019-2024)

Table 63. Global Treatment for Gastroparesis Sales Market Share by Application (2025-2030)

Table 64. Global Treatment for Gastroparesis Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Treatment for Gastroparesis Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Treatment for Gastroparesis Revenue Market Share by Application (2019-2024)

Table 67. Global Treatment for Gastroparesis Revenue Market Share by Application (2025-2030)

Table 68. Global Treatment for Gastroparesis Price (US$/Unit) by Application (2019-2024)

Table 69. Global Treatment for Gastroparesis Price (US$/Unit) by Application (2025-2030)

Table 70. Janssen Global Services Corporation Information

Table 71. Janssen Global Services Description and Business Overview

Table 72. Janssen Global Services Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Janssen Global Services Treatment for Gastroparesis Product

Table 74. Janssen Global Services Recent Developments/Updates

Table 75. Evoke Pharma Corporation Information

Table 76. Evoke Pharma Description and Business Overview

Table 77. Evoke Pharma Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Evoke Pharma Treatment for Gastroparesis Product

Table 79. Evoke Pharma Recent Developments/Updates

Table 80. Cardinal Health Corporation Information

Table 81. Cardinal Health Description and Business Overview

Table 82. Cardinal Health Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Cardinal Health Treatment for Gastroparesis Product

Table 84. Cardinal Health Recent Developments/Updates

Table 85. Salix Pharmaceuticals Corporation Information

Table 86. Salix Pharmaceuticals Description and Business Overview

Table 87. Salix Pharmaceuticals Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Salix Pharmaceuticals Treatment for Gastroparesis Product

Table 89. Salix Pharmaceuticals Recent Developments/Updates

Table 90. Alfa Wassermann Corporation Information

Table 91. Alfa Wassermann Description and Business Overview

Table 92. Alfa Wassermann Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Alfa Wassermann Treatment for Gastroparesis Product

Table 94. Alfa Wassermann Recent Developments/Updates

Table 95. Abbott Laboratories Corporation Information

Table 96. Abbott Laboratories Description and Business Overview

Table 97. Abbott Laboratories Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Abbott Laboratories Treatment for Gastroparesis Product

Table 99. Abbott Laboratories Recent Developments/Updates

Table 100. Medtronic Corporation Information

Table 101. Medtronic Description and Business Overview

Table 102. Medtronic Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Medtronic Treatment for Gastroparesis Product

Table 104. Medtronic Recent Developments/Updates

Table 105. C.R.Bard Corporation Information

Table 106. C.R.Bard Description and Business Overview

Table 107. C.R.Bard Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. C.R.Bard Treatment for Gastroparesis Product

Table 109. C.R.Bard Recent Developments/Updates

Table 110. Rhythm Pharmaceuticals Corporation Information

Table 111. Rhythm Pharmaceuticals Description and Business Overview

Table 112. Rhythm Pharmaceuticals Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Rhythm Pharmaceuticals Treatment for Gastroparesis Product

Table 114. Rhythm Pharmaceuticals Recent Developments/Updates

Table 115. Boston Scientific Corporation Information

Table 116. Boston Scientific Description and Business Overview

Table 117. Boston Scientific Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Boston Scientific Treatment for Gastroparesis Product

Table 119. Boston Scientific Recent Developments/Updates

Table 120. Kimberly-Clark Corporation Information

Table 121. Kimberly-Clark Description and Business Overview

Table 122. Kimberly-Clark Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Kimberly-Clark Treatment for Gastroparesis Product

Table 124. Kimberly-Clark Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Treatment for Gastroparesis Distributors List

Table 128. Treatment for Gastroparesis Customers List

Table 129. Treatment for Gastroparesis Market Trends

Table 130. Treatment for Gastroparesis Market Drivers

Table 131. Treatment for Gastroparesis Market Challenges

Table 132. Treatment for Gastroparesis Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Treatment for Gastroparesis

Figure 2. Global Treatment for Gastroparesis Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Treatment for Gastroparesis Market Share by Type in 2023 & 2030

Figure 4. Drugs Product Picture

Figure 5. Surgical Treatment Products Product Picture

Figure 6. Global Treatment for Gastroparesis Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Treatment for Gastroparesis Market Share by Application in 2023 & 2030

Figure 8. Hospital Pharmacies

Figure 9. Private Clinics

Figure 10. Drug Stores

Figure 11. Retail Pharmacies

Figure 12. E-Commerce

Figure 13. Global Treatment for Gastroparesis Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Treatment for Gastroparesis Market Size (2019-2030) & (US$ Million)

Figure 15. Global Treatment for Gastroparesis Sales (2019-2030) & (K Units)

Figure 16. Global Treatment for Gastroparesis Average Price (US$/Unit) & (2019-2030)

Figure 17. Treatment for Gastroparesis Report Years Considered

Figure 18. Treatment for Gastroparesis Sales Share by Manufacturers in 2023

Figure 19. Global Treatment for Gastroparesis Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Treatment for Gastroparesis Players: Market Share by Revenue in 2023

Figure 21. Treatment for Gastroparesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Treatment for Gastroparesis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Treatment for Gastroparesis Sales Market Share by Country (2019-2030)

Figure 24. North America Treatment for Gastroparesis Revenue Market Share by Country (2019-2030)

Figure 25. United States Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Treatment for Gastroparesis Sales Market Share by Country (2019-2030)

Figure 28. Europe Treatment for Gastroparesis Revenue Market Share by Country (2019-2030)

Figure 29. Germany Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Treatment for Gastroparesis Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Treatment for Gastroparesis Revenue Market Share by Region (2019-2030)

Figure 36. China Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Treatment for Gastroparesis Sales Market Share by Country (2019-2030)

Figure 46. Latin America Treatment for Gastroparesis Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Treatment for Gastroparesis Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Treatment for Gastroparesis Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. UAE Treatment for Gastroparesis Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Treatment for Gastroparesis by Type (2019-2030)

Figure 56. Global Revenue Market Share of Treatment for Gastroparesis by Type (2019-2030)

Figure 57. Global Treatment for Gastroparesis Price (US$/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Treatment for Gastroparesis by Application (2019-2030)

Figure 59. Global Revenue Market Share of Treatment for Gastroparesis by Application (2019-2030)

Figure 60. Global Treatment for Gastroparesis Price (US$/Unit) by Application (2019-2030)

Figure 61. Treatment for Gastroparesis Value Chain

Figure 62. Treatment for Gastroparesis Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions